News
CytoMed Therapeutics (NASDAQ:GDTC) CytoMed Therapeutics (GDCT, or the Company), a Singapore-based biotechnology company trading on the NASDAQ, is developing multiple gamma delta chimeric antigen...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Vasily Zyryanov is an individual investor and writer.He uses various techniques to find both relatively underpriced equities with...
News
This article was written by Follow David A. Johnson is founder and principal of Endurance Capital Management, a New Jersey Limited Liability Company. As...
News
This article was written by Follow Nick Ackerman is a former financial advisor using his experience to provide coverage on closed-end funds and exchange-traded...
News
Atai Life Sciences (NASDAQ:ATAI) has been making great progress in advancing several drugs from its pipeline on multiple fronts. In particular, it is advancing...
News
More than a year ago, the Federal Trade Commission sued Intuit Inc., the maker of TurboTax, for allegedly tricking people into thinking they could...
News
Intro Winnebago Industries, Inc. (NYSE:WGO), based in Minnesota, has been making recreational vehicles since 1958. They generated around $5 billion in revenue as of...
News
After the recent pullback in its unit price, I now consider Dorchester Minerals, L.P. (NASDAQ:DMLP) undervalued after previously having a hold rating on it....
News
Dear Quentin, I have spoken with an attorney, but I see several online will services that are very inexpensive that include a will and...
News
One of the things that makes investing difficult is the fact that circumstances can change. Sometimes, those changes can occur rather rapidly. And when...
News
Not only are interest rates in the U.S. at their highest level in decades, the yield curve is inverted. Three-month U.S. Treasury bills BX:TMUBMUSD03M...
News
Federal Reserve Chairman Jay Powell, in his speech at Jackson Hole, assured the world that the Fed would do what was necessary to bring...
News
Summary I am following up on my previous coverage on Samsara (NYSE:IOT), where I recommended a hold rating as I believed there were a...
